Novogen Limited, an Australian biotechnology company, announced a collaboration agreement to develop cosmetic applications. The finished products will be manufactured and distributed by a leading cosmetics company. The company collaborating with Novogen was not disclosed in the announcement.
Novagen has reported that preliminary research shows that a number of Novogen's compounds have potential in various cosmetic applications. Novogen's patent position is said to benefit the cosmetics industry at large.
Novogen will continue its development of wound care applications, treatment of burned tissue, hair growth treatments, prescription treatment of skin diseases or skin cancer, injectables of antidote formulations, or transdermal delivery of pharmaceutical formulations.